Gastrointestinal Testing Panels Market

A prominent research firm, Cognizance Market Research added a cutting-edge industry report on the “Global Gastrointestinal Testing Panels Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2023 to 2030.

Global Gastrointestinal Testing Panels Market Analysis

According to cognizance market research, the global gastrointestinal testing panels market was valued at US$ 54.9 Million in 2022 and is anticipated to reach US$ 79.8 Million by the end of 2030 with a CAGR of 4.8% from 2023 to 2030.

What are Gastrointestinal Testing Panels?

A complete panel created to identify the most common gastrointestinal illnesses using a molecular method is referred to as a gastrointestinal testing panel. A gastrointestinal testing panel provides fast and precise findings that the doctor can examine and make a prognosis based on the condition and its intensity.

Adenovirus, Campylobacter jejuni, Campylobacter upsaliensis, Campylobacter coli, and Clostridioides difficile are among the bacteria that can be found using gastrointestinal diagnostic kits. Salmonella spp., Norovirus GI, Norovirus GII, Enteroinvasive Escherichia coli, Enteroaggregative Escherichia coli, Enterotoxigenic Escherichia coli, Enterohemorrhagic Escherichia coli, Yersinia enterocolitica, Escherichia coli, and Endogenous Control are among the pathogens that can cause illness.

The panels may find co-infections and detect the existence of microbes that a medical professional might not otherwise notice (more than one cause for the infection). This enables earlier and more precise therapy (if necessary). It’s possible for test results to be accessible in a short while. Due to the GI panels’ recent development, laboratories and healthcare practitioners are still figuring out the best ways to use them to deliver the best patient outcomes at the lowest possible expense. If a microbe is not detected by the panel or if there is a suspect of a microbe other than those listed in the GI panel, additional tests, such as stool culture and O&P, may be conducted.

The efficacy of therapy is not checked with GI tests. Instead of using a GI panel to assess whether therapy has successfully treated the infection, a test that is particular for the microbe(s) causing the infection would be used once they have been found. For instance, this might be done if a foodborne disease epidemic is occurring. Follow-up testing would be given to food workers to make sure they are no longer shedding the virus and won’t transmit it to others.

Global Gastrointestinal Testing Panels Market Outlook

In the Gastrointestinal testing panels report, the market outlook segment mainly includes important dynamics of the market which include drivers, restraints, opportunities and challenges tackled by the industry. Opportunities and challenges are extrinsic factors whereas, drivers and restraints are intrinsic factors of the market.

Growth in the market is driven by rising elderly population and rising instances of gastrointestinal problems as well as growing demand for gastrointestinal testing panels. Due to rising health consciousness, the market for gastrointestinal testing panels is anticipated to expand steadily after the coronavirus breakdown. The market for gastrointestinal testing panels is significantly fueled by the increasing incidence of gastrointestinal diseases in these regions. Growing rates of gastrointestinal diseases are largely due to unhealthy eating practices, an active lifestyle, disturbed sleep patterns, and excessive stress. The main reasons for an increase in diarrheal disease instances in some developing nations are a lack of adequate healthcare services and unhygienic behaviour. In addition to diarrhea, patients also experience abdominal discomfort and vomiting as signs.

One of the key driving forces behind the expansion of the market for gastrointestinal testing panels is the growing elderly population. These individuals are much more likely to acquire inflammatory bowel conditions like Crohn’s disease, ulcerative colitis, IBS, etc. Inflammatory bowel disorders are very prevalent in the elderly community. Due to decreased gut stem cell regeneration and decreased gastric fluid output in older individuals, this has occurred.

The demand for gastrointestinal testing panels is anticipated to increase over the projection period as a result of developments in the pharmaceutical and healthcare sectors, growing healthcare costs, and an ageing population. Market expansion in the healthcare sector is supported by favourable payment policies. Regular GI testing arrays are required due to the rising frequency of gastrointestinal problems and digestive diseases. To meet the demand from the healthcare sector, manufacturers in the market for gastrointestinal diagnostic strips are producing more of these instruments. Market participants are launching cutting-edge goods to meet the rising demand from hospitals, diagnostic labs, etc., in an effort to improve peoples’ general well-being.

Segment Analysis:

The global gastrointestinal testing panels market has been segmented into pathogen type, type, end-user and geography.

On the basis of pathogen type, the gastrointestinal testing panels market has been segmented into viruses, bacteria and parasite.

On the basis of type, the market for gastrointestinal testing panels has been further classified into syndromic full, multiplex panel and low plex panel.

On the basis of end-user, the gastrointestinal testing panels market has been segmented into hospitals, diagnostic, laboratories, point-of-care and others.

Geographical Analysis:

Based on geography the global gastrointestinal testing panels have been segmented into five main regions namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Europe and Middle East Africa dominate the gastrointestinal testing panels market. Rises in the prevalence and incidence of gastrointestinal diseases like gastroesophageal reflux disease, irritable bowel syndrome, and inflammatory bowel diseases (Crohn’s disease, ulcerative colitis), as well as an increase in the geriatric population, are all factors contributing to the growth of the gastrointestinal testing panels market in Europe, the Middle East, and Africa.

The geriatric community, defined as those 65 and older, has grown considerably over the past few years, and by 2050, it is expected to make up more than 16.7% of the world’s population, according to the U.S. Census Bureau. The prevalence of gastrointestinal diseases is high in the aged, and approximately 65% of this group suffers from various gastrointestinal problems.